ASP ISOTOPES INC (ASPI) Stock Fundamental Analysis

NASDAQ:ASPI • US00218A1051

5.2 USD
-0.26 (-4.76%)
At close: Feb 20, 2026
5.1254 USD
-0.07 (-1.43%)
After Hours: 2/20/2026, 8:17:33 PM
Fundamental Rating

2

ASPI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. The financial health of ASPI is average, but there are quite some concerns on its profitability. ASPI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ASPI has reported negative net income.
  • ASPI had a negative operating cash flow in the past year.
ASPI Yearly Net Income VS EBIT VS OCF VS FCFASPI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • ASPI has a Return On Assets of -73.55%. This is amonst the worse of the industry: ASPI underperforms 98.80% of its industry peers.
  • ASPI has a worse Return On Equity (-396.17%) than 93.98% of its industry peers.
Industry RankSector Rank
ROA -73.55%
ROE -396.17%
ROIC N/A
ROA(3y)-45.32%
ROA(5y)N/A
ROE(3y)-74.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASPI Yearly ROA, ROE, ROICASPI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • ASPI has a Gross Margin of 39.26%. This is amongst the best in the industry. ASPI outperforms 81.93% of its industry peers.
  • ASPI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASPI Yearly Profit, Operating, Gross MarginsASPI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K

4

2. Health

2.1 Basic Checks

  • ASPI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ASPI has more shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, ASPI has a worse debt to assets ratio.
ASPI Yearly Shares OutstandingASPI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
ASPI Yearly Total Debt VS Total AssetsASPI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ASPI has an Altman-Z score of 2.33. This is not the best score and indicates that ASPI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ASPI (2.33) is better than 61.45% of its industry peers.
  • ASPI has a Debt/Equity ratio of 3.98. This is a high value indicating a heavy dependency on external financing.
  • ASPI's Debt to Equity ratio of 3.98 is on the low side compared to the rest of the industry. ASPI is outperformed by 91.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.98
Debt/FCF N/A
Altman-Z 2.33
ROIC/WACCN/A
WACC15.35%
ASPI Yearly LT Debt VS Equity VS FCFASPI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • ASPI has a Current Ratio of 14.72. This indicates that ASPI is financially healthy and has no problem in meeting its short term obligations.
  • ASPI has a Current ratio of 14.72. This is amongst the best in the industry. ASPI outperforms 98.80% of its industry peers.
  • ASPI has a Quick Ratio of 14.56. This indicates that ASPI is financially healthy and has no problem in meeting its short term obligations.
  • ASPI's Quick ratio of 14.56 is amongst the best of the industry. ASPI outperforms 98.80% of its industry peers.
Industry RankSector Rank
Current Ratio 14.72
Quick Ratio 14.56
ASPI Yearly Current Assets VS Current LiabilitesASPI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

4

3. Growth

3.1 Past

  • The earnings per share for ASPI have decreased strongly by -134.39% in the last year.
  • ASPI shows a strong growth in Revenue. In the last year, the Revenue has grown by 147.78%.
EPS 1Y (TTM)-134.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)147.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%349.86%

3.2 Future

  • The Earnings Per Share is expected to grow by 40.58% on average over the next years. This is a very strong growth
  • ASPI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 162.72% yearly.
EPS Next Y-107.02%
EPS Next 2Y5.69%
EPS Next 3Y4.65%
EPS Next 5Y40.58%
Revenue Next Year106.43%
Revenue Next 2Y222.37%
Revenue Next 3Y186.58%
Revenue Next 5Y162.73%

3.3 Evolution

ASPI Yearly Revenue VS EstimatesASPI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
ASPI Yearly EPS VS EstimatesASPI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

0

4. Valuation

4.1 Price/Earnings Ratio

  • ASPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ASPI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASPI Price Earnings VS Forward Price EarningsASPI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASPI Per share dataASPI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.69%
EPS Next 3Y4.65%

0

5. Dividend

5.1 Amount

  • ASPI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ASP ISOTOPES INC

NASDAQ:ASPI (2/20/2026, 8:17:33 PM)

After market: 5.1254 -0.07 (-1.43%)

5.2

-0.26 (-4.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-19
Earnings (Next)03-30
Inst Owners48.23%
Inst Owner Change16.37%
Ins Owners11.5%
Ins Owner Change5.03%
Market Cap650.57M
Revenue(TTM)8.38M
Net Income(TTM)-99.96M
Analysts82.22
Price Target13.26 (155%)
Short Float %19.17%
Short Ratio3.53
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-417.82%
Min EPS beat(2)-818%
Max EPS beat(2)-17.65%
EPS beat(4)0
Avg EPS beat(4)-226.99%
Min EPS beat(4)-818%
Max EPS beat(4)-17.65%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-21.75%
Min Revenue beat(2)-26.57%
Max Revenue beat(2)-16.92%
Revenue beat(4)0
Avg Revenue beat(4)-12.27%
Min Revenue beat(4)-26.57%
Max Revenue beat(4)-2.45%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)18.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.67%
EPS NY rev (1m)0%
EPS NY rev (3m)11.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-31.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-42.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 142
P/FCF N/A
P/OCF N/A
P/B 25.78
P/tB 29.75
EV/EBITDA N/A
EPS(TTM)-1.42
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.04
BVpS0.2
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.55%
ROE -396.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.26%
FCFM N/A
ROA(3y)-45.32%
ROA(5y)N/A
ROE(3y)-74.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 3.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1289.23%
Cap/Sales 253.45%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 14.72
Quick Ratio 14.56
Altman-Z 2.33
F-Score3
WACC15.35%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-134.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y-107.02%
EPS Next 2Y5.69%
EPS Next 3Y4.65%
EPS Next 5Y40.58%
Revenue 1Y (TTM)147.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%349.86%
Revenue Next Year106.43%
Revenue Next 2Y222.37%
Revenue Next 3Y186.58%
Revenue Next 5Y162.73%
EBIT growth 1Y-55.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-36.45%
EBIT Next 3Y21.27%
EBIT Next 5YN/A
FCF growth 1Y-316.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-361.77%
OCF growth 3YN/A
OCF growth 5YN/A

ASP ISOTOPES INC / ASPI FAQ

What is the ChartMill fundamental rating of ASP ISOTOPES INC (ASPI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ASPI.


What is the valuation status for ASPI stock?

ChartMill assigns a valuation rating of 0 / 10 to ASP ISOTOPES INC (ASPI). This can be considered as Overvalued.


How profitable is ASP ISOTOPES INC (ASPI) stock?

ASP ISOTOPES INC (ASPI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ASPI stock?

The Earnings per Share (EPS) of ASP ISOTOPES INC (ASPI) is expected to decline by -107.02% in the next year.